Neuroinflammation

Neuroinflammation is the inflammatory response within the central nervous system (CNS), which comprises the brain and spinal cord. It is a complex biological process mediated primarily by the brain's resident immune cells, known as microglia, and supported by other glial cells like astrocytes. When the CNS detects a threat—such as an infection, traumatic injury, toxins, or protein aggregates associated with neurodegenerative diseases—these cells become activated. In their activated state, they change shape and release a variety of signaling molecules, including cytokines, chemokines, and reactive oxygen species, to recruit other cells and neutralize the threat.

This response serves a protective function in its acute form. By orchestrating the removal of pathogens, dead cells, and other harmful debris, acute neuroinflammation is a critical part of the brain's healing and repair mechanisms. However, when the initial trigger is not resolved or the inflammatory response becomes self-perpetuating, it can transition into a chronic state. Chronic neuroinflammation is widely considered to be detrimental, as the sustained release of inflammatory molecules can create a toxic environment that damages and kills healthy neurons, disrupts synaptic communication, and contributes to the progression of neurological disorders.

The concept of neuroinflammation has fundamentally shifted our understanding of brain health and disease. For many years, the brain was considered an "immune-privileged" site, isolated from the body's peripheral immune system by the blood-brain barrier (BBB). While the BBB does provide a significant protective barrier, it is now understood that this privilege is not absolute. There is constant communication between the central and peripheral immune systems. During injury or disease, the BBB can become more permeable, allowing immune cells from the bloodstream to enter the brain, further amplifying the inflammatory cascade. This interplay highlights that neurological disorders cannot be viewed in isolation from the body's overall immune status.

The role of chronic neuroinflammation is a critical factor in the pathology of a wide range of debilitating conditions. It is a hallmark feature of neurodegenerative diseases such as Alzheimer's disease, where it is linked to the accumulation of amyloid plaques and tau tangles, and Parkinson's disease, where it contributes to the loss of dopamine-producing neurons. It is also central to autoimmune disorders like multiple sclerosis, where the immune system mistakenly attacks the myelin sheath that protects nerve fibers. Furthermore, research has implicated neuroinflammation in the aftermath of stroke and traumatic brain injury, as well as in psychiatric conditions like major depressive disorder. Understanding the mechanisms that drive and sustain neuroinflammation is therefore a major frontier in medical science, as targeting these pathways offers promising new therapeutic strategies for treating some of the most challenging brain disorders.